Last reviewed · How we verify

NCT06610370

Predicting Postoperative Ambulation Following Selective Dorsal Rhizotomy Based on Preoperative Gross Motor Function Score

Completed Last updated 26 September 2024
What this trial tests

trial testing Group 1 in Spastic Cerebral Palsy in 95 participants. Completed in 1 June 2024.

Timeline
1 September 2023
Primary endpoint
1 June 2024
1 June 2024

Quick facts

Lead sponsorAcıbadem Atunizade Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment95
Start date1 September 2023
Primary completion1 June 2024
Estimated completion1 June 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Acıbadem Atunizade Hospital

Who can join

Adults 1 Day to 17, any sex, with Spastic Cerebral Palsy or Walking, Difficulty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cerebral Palsy (CP) is a neurodevelopmental disorder characterized by abnormalities in muscle tone, movement, and motor skills resulting from permanent, nonprogressive damage to the developing brain before, during, or after birth (Tedla \& Reddy, 2021). The worldwide prevalence of CP is 2-3 per 1000 live births (Paul et al., 2022). The most common type of CP is spastic, accounting for approximately 85% of all CP cases (Paul et al., 2022). It is divided into 3 types: hemiparetic, diparetic, and quadriparetic. Selective Dorsal Rhizotomy (SDR) is a surgical technique applied for spasticity management in children with bilateral spastic type CP (Novak et al., 2014). One of the most important points in the decision-making process for SDR surgery is the compatibility of the family's expectations with the expectations of the healthcare professional. Informing the family about the expectations is very important in the decision-making process for surgery (Waite et al., 2023). No study has been found in the literature that provides objective predictive value before surgery in terms of postoperative ambulation. The aim of this study is to examine the predictability of postoperative ambulation status in patients with Spastic Cerebral Palsy (SCP) according to the Gross Motor Function Measure-88 (GMFM-88) score before SDR.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Group 1

Trials testing the same drug.

Other recruiting trials for Spastic Cerebral Palsy

Currently open trials in the same condition.

Other Acıbadem Atunizade Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06610370.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing